WCN26-6941 Prednisolone Monotherapy versus Low-Dose Prednisolone and Rituximab Therapy in Primary Focal Segmental Glomerulosclerosis and Minimal Change Disease - A randomised control trial in a tertiary center of Eastern part of India
20260 citationsJournal Articlegold Open Access
Field-Weighted Citation Impact: 0.00
WCN26-6941 Prednisolone Monotherapy versus Low-Dose Prednisolone and Rituximab Therapy in Primary Focal Segmental Glomerulosclerosis and Minimal Change Disease - A randomised control trial in a tertiary center of Eastern part of India | Researchclopedia